Genomics: University of Texas, MD Anderson

Total Score People Score Events Score
84 73 37
Date Event Presentation Speakers
June 24, 2014 Microbiology after the Genomics Revolution (Genomes 2014) Session 7: Host genetics and model systems George Weinstock
March 5, 2014 Targeted Anticancer Therapies Preclinical Models in the Development of Cancer Therapeutics Lee M Ellis
March 5, 2014 4th ASM Conference on Enterococci Enterococcal Virulence Barbara E Murray
January 30, 2014 Genitourinary Cancers Symposium A Decade in Review: Prostate Cancer Deborah Kuban
January 6, 2014 AACR-IASLC Joint Conference on the Molecular Origins of Lung Cancer Concurrent Sessions 3-4 John D Minna, Roy S. Herbst
Concurrent Sessions 1-2 John V Heymach, Ignacio I. Wistuba, Garth Powis
Plenary Session 2: Clinical Trial Design and Master Protocols Roy S. Herbst, J. Jack Lee
Opening Session Roy S. Herbst
May 31, 2013 ASCO Annual Meeting 2013 Management of Chronic Lymphocytic Leukemia (M10) William G. Wierda
Education Sessions Anas Younes
Education Sessions John de Groot
Special Session Razelle Kurzrock, Gabriel N Hortobagyi
Education Sessions Robert L. Coleman
Educations Sessions Jeffrey E Gershenwald, Stanley Hamilton
April 6, 2013 AACR Annual Meetings Drug Discovery in Industry, Academia, and Government: What Is the Track Record? Michael A. White
Clinical Trial Design in the Genomic Era Co-Chairpersons: Donald A. Berry, The University of Texas MD Anderson Cancer Center, Houston, TX, and George W. Sledge, Jr., Stanford University School of Medicine, Stanford, CA Donald Berry
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Gordon Mills
Bridging the Gap Between Clinical Research and Laboratory Investigation: Utilizing Presurgical Clinical Trials to Investigate Anti-CTLA-4 Immunotherapy Padmanee Sharma, The University of Texas MD Anderson Cancer Center, Houston, TX Padmanee Sharma
Whole Body Metabolism and Cancer Chairperson: Philipp E. Scherer, UT Southwestern Medical Center, Dallas, TX Philipp Scherer
Tumor-Secreted Factors Chairperson: David C. Lyden, Weill Cornell Medical College of Cornell University, New York, NY George A. Calin
Identifying Novel Redox Signaling Pathways for Cancer Chemoprevention: From Fly to the Mouse Garth Powis, The University of Texas MD Anderson Cancer Center, Houston, TX Garth Powis
PAK Family of Kinases in Human Cancer: Past, Present, and Future Rakesh Kumar, George Washington University, Washington, DC Rakesh Kumar
August 24, 2012 21st Annual Short Course on Experimental Models of Human Cancer P53 Guillermina Lozano
January 15, 2012 Drug Discovery for Protozoan Parasites (J1) Pre-Clinical Development Michael Wang
December 13, 2011 New Horizons in Cancer Research: Biology to Prevention to Therapy Genomic alterations in gingivobuccal cancer: Results from whole-exome resequencing Sadhan Majumder
Prostaglandin E2 promotes intestinal tumor growth via DNA methylation Raymond N DuBois
Plenary Session 5 | Cancer Prevention and Chemoprevention Raymond N DuBois
Day in Review Raymond N DuBois
Session 4 | Molecular Epidemiology of Cancer: Towards Personalized Risk Assessment, Prevention, and Therapy Xifeng Wu
December 1, 2011 9th International Conference on Ovarian Cancer Novel imaging for Ovarian Cancer Homer A. Macapinlac
Secondary Surgical Cytoreduction Pedro T. Ramirez
Session III | Surgery Debates Robert L. Coleman
Use of Biomarkers to Personalize Care for Epithelial Ovarian Cancer Robert C Bast
Angiogenesis Inhibitors in Clinical Practice Robert L. Coleman
October 10, 2011 15th Annual Meeting Collaborative Group of the Americas, on Inherited Colorectal Cancer (CGA-ICC) Hot Topics | Basic Science C. Richard Boland
Improving Endoscopic Identification of Colorectal Neoplasms in Hereditary Colon Cancer Syndromes Patrick M Lynch
August 7, 2011 Mobile DNA in Mammalian Genomes Comparative genomics of mammalian mobile elements Cedric Feschotte
Session 7 | Mobile Element Evolution Cedric Feschotte
July 30, 2011 MD Anderson Physicians Network Symposium Changing Paradigms in Cancer Treatment and Patient Management Non-Small Cell Lung Cancer | Combined Modality Therapy for Patients with Stage II/III Disease Scott M Lippman
Making Sense of Multigene Assays in Practice Ana Gonzalez-Angulo
HER-2 Directed Therapies: Adjuvant or Neoadjuvant? Ana Gonzalez-Angulo
Challenging Case Presentations and Interactive Audience Participation Deborah Kuban
Dose Escalation and Stereotactic Therapy in the Management of Pancreatic Cancer Sunil Krishnan
Active Surveillance vs. Treatment in the Management of Prostate Cancer Deborah Kuban
Molecular Markers Guiding Diagnosis and Optimizing Management of Leukemias Stefan Faderl
Emerging Paradigms in the Management of Myeloproliferative Disorders Stefan Faderl
New Therapeutic Targets in Lymphoma | The B-cell Receptor, CD-30 Fredrick B Hagemeister
PET Scan in Lymphoma: Which Histologies? When? Can it Guide Treatment? Fredrick B Hagemeister
Advances in RT: IMRT, Short Course and Selective Omission of RT Sunil Krishnan
April 1, 2011 Metabolic Responses to Extreme Conditions (D4) Immune Function and Calorie Restriction Christopher Jolly
March 27, 2011 Congress on Steroid Research Metabolic impact of sex hormones on obesity Deborah Joy Clegg
March 27, 2011 Autophagy (D1) Workshop 2: Autophagy and Disease: A Clinical Point of View Beth Levine
Autophagy and Exercise Beth Levine
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma How I Manage Relapsed/Refractory Chronic Lymphocytic Leukemia William G. Wierda
Comment William G. Wierda
HDAC Function and HDAC Inhibitors: Where Is the Selectivity? Jean-Pierre Issa
Epigenetics and the Biology of Hematologic Malignancies Anas Younes
Afternoon Workshop | Epigenetics and Gene Expression Anas Younes
Comment Jean-Pierre Issa
The Nature of Future MoAbs in Leukemia William G. Wierda
Non-Hodgkin Lymphoma: Conjugated and Nonconjugated MoAbs Anas Younes
Chronic Lymphocytic Leukemia William G. Wierda
Acute Myeloid Leukemia | Myelodysplastic Syndromes Jean-Pierre Issa
September 12, 2010 Joint Metastasis Research Society-AACR Conference in Conjunction with the Tumor Microenvironment Working Group of the AACR Special Presentation | Title to be announced S. Ward Casscells
The biology behind the successes and failures of VEGF-targeted therapies Lee M Ellis
Comparing genomics of primary tumors and metastases for targets identification and biomarkers development in lung cancer Ignacio I. Wistuba
July 11, 2010 Translational Cancer Medicine 2010 (USA) Toward personalized therapy for advanced non-small cell lung cancer: The M. D. Anderson BATTLE Programs Roy S. Herbst
February 11, 2010 Second Annual Conference The Sixth Vital Sign: What Every Oncologist Should Know About Molecular Oncology: Applications to Patient Care Rare Tumors: A Personalized Therapy Approach With a Case History Razelle Kurzrock
November 6, 2009 Translating Scientific Advances Into Clinical Care for Cancer Multiple Myeloma Robert Z. Orlowski
September 23, 2009 TRACK 4: Bridging Silos in Biomarker Development : Third Annual Biomarker Data Analysis Systems Approach to Biomarker Identification Gordon Mills
August 11, 2009 Inaugural Molecular Diagnostics for Infectious Disease Next Generation Microbial Genomics George Weinstock
Emerging and Re-Emerging Infectious Diseases: Molecular Diagnostic Approaches Juan P. Olano
June 8, 2009 Genotyping Tools Rare Functional SNPs and the Genetic Architecture of Complex Diseases Ivan Gorlov
January 26, 2009 Biomarker Assay Development Circulating Tumor Cell Assays: A Prognostic and Predictive Factor For Breast, Prostate And Colon Cancer Herbert A Fritsche
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Application of New Proteomics Technologies to Drug Discovery : Track 1-3 Yingming Zhao
Title: TBD:Track 2-2 Dihua Yu
Feedstock and Enzyme Improvement for Bioenergy : Track 5-1 Joshua S. Yuan
November 6, 2008 The 2008 Research Conference on Food, Nutrition, Physical Activity & Cancer Omega-3 Fatty Acids and Cancer Prevention Robert S. Chapkin
March 4, 2008 Maintenance of Genome Stability Conference 2008 Session 3: DSB repair and its control (Chair: Joe Jiricny) Tanya Paull
February 24, 2008 GENES & BEHAVIOR Sex chromosome evolution driven by sexual selection and sexual antagonism Mark Kirkpatrick
February 3, 2008 Biomarker Discovery, Validation and Applications Multiplex Biomarkers and System Response Profiles Gordon Mills
January 22, 2008 Ubiquitin and Cancer: From Molecular Targets and Mechanisms to the Clinic Ubiquitin Signaling in the NF-kB Pathway Zhijian James Chen
Modulation of Transcription Factor Activity by Mono-ubiquitylation Thomas Kodadek
Proteasome Inhibitors and ER Stress in Pancreatic Cancer David J. McConkey
December 1, 2007 47TH American Socieity of Cell Biology Cell Matrix Interactions (Room 140A) Muhammad H. Zaman
Cellular Biology of Gap Junction Channels (Room 103A) Guillermo Altenberg, Srikanth Polusani
Translocon-mediated Head-First Insertion and Rotation of a Signal Anchor during Cotranslational Integration. A E Johnson
Mechanism of the Neurospora Circadian Negative Feedback Loop. Yi Liu
July 28, 2007 From Unfolded Proteins in the Endoplasmic Reticulum to Disease Real-time Fluorescence Detection of ERAD Substrate Retro-translocation in a Mammalian In Vitro System Art E Johnson
Role of ER Stress Singaling Pathway During Cytokinesis Sankar N Maity
July 21, 2007 Ciliate Molecular Biology Tetrahymena ORC contains a ribosomal RNA fragment that participates in rDNA origin recognition Geoffrey Kapler
July 7, 2007 CHROMATIN AND TRANSCRIPTION In vivo functions of histone modifying enzymes Sharon Dent
Mec1/Tel1 phosphorylation of the INO80 chromatin remodeling complex influences DNA damage checkpoint responses Xuetong Shen
TAP-ing into the p53-proteome Michelle Barton
June 9, 2007 Transport ATPases: Structure, Mechanisms, Genomics and Disease The mechanochemistry of ABC Transporters Philip J Thomas
V-ATPases in cancer and angiogenesis Raul Martinez Zaguilan
3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.